Results 51 to 60 of about 114,322 (384)
Polypharmacy for schizophrenia [PDF]
Current Opinion in Psychiatry, 2013 Combining psychotropic medications is common for people diagnosed with schizophrenia facing a variety of clinical circumstances. This review provides an update on evidence regarding the effectiveness of polypharmacy approaches.Epidemiology studies have demonstrated that polypharmacy is extremely common, but evidence regarding all polypharmacy ...
Jacob S. Ballon, T. Scott Stroup
openaire +2 more sources
Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy [PDF]
, 2016 Myotonic dystrophy (DM) and facioscapulohumeral muscular dystrophy (FSHD) are the two most common adult muscular dystrophies and have progressive and often disabling manifestations.
Conn, Kelly +7 more
core +2 more sources
Preventing Chronic Disease, 2022 Introduction To date, no study has investigated the impact of polypharmacy (use of ≥5 medications concurrently) on health-related quality of life (HRQOL) and psychological distress in a combined sample of chronic disease patients and patients with ...
L. Van Wilder +5 more
semanticscholar +1 more source
Prevalence and predictors of polypharmacy among Korean elderly.
PLoS ONE, 2014 ObjectivePolypharmacy is widespread in the elderly because of their multiple chronic health problems. The objective of this study was to investigate the prevalence and predictors associated with polypharmacy in a nationally representative sample of ...
Hong-Ah Kim +3 more
doaj +1 more source
The epidemiology of polypharmacy [PDF]
Clinical Medicine, 2016 Polypharmacy describes, in simplistic terms, the use of multiple medications in an individual. It has become a normal aspect of modern medicine, driven by an ageing, multimorbid population, the increasing availability of preventative medications and an increasing use of single-disease guidelines and adherence to evidence-based practice.
openaire +5 more sources
Polypharmacy in schizophrenia [PDF]
Basic & Clinical Pharmacology & Toxicology, 2020 AbstractSchizophrenia is a severe mental disorder characterized by a heterogeneous symptom profile which comprises a clinical platform for widespread use of polypharmacy even though antipsychotic monotherapy is the recommended treatment regimen. This narrative review provides a summary of the current gap between evidence and practice for use of ...
openaire +3 more sources
What is the epidemiology of medication errors, error-related adverse events and risk factors for errors in adults managed in community care contexts? A systematic review of the international literature [PDF]
, 2018 © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Objective To investigate the epidemiology of medication errors and ...
Aljadhey, Hisham +6 more
core +3 more sources
Frontiers in Pharmacology, 2022 Objectives: Polypharmacy and potentially inappropriate medication (PIM) use among elderly Chinese patients have not yet been investigated by systematic review and meta-analysis.
F. Tian, Zhaoyan Chen, Jinhui Wu
semanticscholar +1 more source
JGH Open, 2023 Background and Aim Polypharmacy and sarcopenia are increasing public health problems worldwide. However, data on the prevalence, association, and prognostic significance of polypharmacy and sarcopenia in patients with liver cirrhosis are limited. Methods
Tatsunori Hanai +7 more
doaj +1 more source
Challenges of managing people with multimorbidity in today’s healthcare systems [PDF]
, 2015 Multimorbidity is a growing issue and poses a major challenge to health care systems around the world. Multimorbidity is related to ageing but many studies have now shown that it is also socially patterned, being more common and occurring at an earlier ...
Mercer, Stewart, Moffat, Keith
core +3 more sources